Additional Gold Discoveries for Harfang on its Serpent Property (James Bay, Québec)
MONTREAL, Dec. 10, 2019 (GLOBE NEWSWIRE) — Harfang Exploration Inc. (“Harfang”) (TSX-V: HAR) is pleased to report additional high-grade gold […]
Eastman Announces Retirement of Chief Financial Officer Curtis E. Espeland
KINGSPORT, Tenn., Dec. 10, 2019 (GLOBE NEWSWIRE) — Eastman Chemical Company (NYSE:EMN) today announced that, after nearly 25 years of […]
Fiber Innovator Forked Deer Electric Cooperative Takes Rural Communities from Zero to a Thousand with AXOS
SAN JOSE, Calif., Dec. 10, 2019 (GLOBE NEWSWIRE) — Calix, Inc. (NYSE: CALX) today announced that Forked Deer Electric Cooperative […]
AgraFlora Organics obtient une licence de recherche de Santé Canada pour son usine d’embouteillage certifiée GMP située à Toronto en Ontario et augmente son offre de débentures convertibles
VANCOUVER, Colombie-Britannique, 10 déc. 2019 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc. (« AgraFlora » ou la « Société ») (CSE : AGRA) (Frankfurt: PU31) […]
Fidelity D & D Bancorp, Inc. to Acquire MNB Corporation
DUNMORE, Pa., Dec. 10, 2019 (GLOBE NEWSWIRE) — Fidelity D & D Bancorp, Inc. (NASDAQ: FDBC) (“Fidelity”), the parent bank […]
National Experts in Autoimmunity Tapped to Serve on Exagen’s Scientific Advisory Board
SAN DIEGO, Dec. 10, 2019 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum […]
Microchip Unveils Family Details and Opens Early Access Program for RISC-V Enabled Low-Power PolarFire SoC FPGA Family
CHANDLER, Ariz., Dec. 10, 2019 (GLOBE NEWSWIRE) — RISC-V Summit — The trend towards compute intensive gateways and edge devices […]
BeyondSpring’s Study 106 Phase 3 Superior Trial Design Combining Plinabulin with Pegfilgrastim Versus Pegfilgrastim Alone for Chemotherapy-Induced Neutropenia Presented at ASH 2019 Annual Meeting
NEW YORK, Dec. 10, 2019 (GLOBE NEWSWIRE) — BeyondSpring Inc. (NASDAQ: BYSI), a global biopharmaceutical company focused on the development […]
Vaccinex Announces $3 Million Award from the Alzheimer’s Drug Discovery Foundation
ROCHESTER, N.Y., Dec. 10, 2019 (GLOBE NEWSWIRE) — Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering novel antibody therapies […]
Ability Inc. Announces Securities and Exchange Commission Settlement
TEL AVIV, ISRAEL, Dec. 10, 2019 (GLOBE NEWSWIRE) — Ability Inc. (Nasdaq: ABIL) (the “Company”), a leading provider of innovative […]
